News about Global Pharma

Recipharm Announces Collaboration with Oz-UK

The pMDIs will utilise valves and actuators from Recipharm’s Bespak brand, and a new generation of low global warming potential (GWP) propellants.

Global Pharma | 06/12/2023 | By Manvi |  533

Akums Drugs and Pharma Acquires New Facility in Baddi

This facility, the 12th under Akums and the second in Baddi, will enhance the company's tablet manufacturing capacity, as per the release.

Global Pharma | 06/12/2023 | By Manvi |  1262

Bry-Air Organizes its 13th Biannual Eye Camp at Moga, Punjab

Staying true to its commitment to enhancing lives through CSR activities, Bry-Air, the flagship company of Pahwa Group, organized its 13th Biannual Eye Camp at Moga, Punjab. The camp was conducted on 3rd December at Mathra Das Civil Hospital in association with a local NGO partner, Bhartiya Jagriti Manch.

Global Pharma | 06/12/2023 | By Manvi |  472

Strides Launches Icosapent Ethyl Acid Soft Gel Capsules in Partnership with Amneal

The product has been in-licensed from Strides, a global pharmaceutical manufacturer, and will be commercialized by Amneal starting in the fourth quarter of 2023.

Global Pharma | 05/12/2023 | By Manvi |  944

Alkem Laboratories Ltd Gets 3 observations from USFDA for API Manufacturing Facility

The US FDA had conducted an inspection at Alkem Laboratories Limited's API manufacturing facility located at Mandva.

Global Pharma | 05/12/2023 | By Manvi |  784

Hovione Expands Nasal Drug Delivery in Collaboration with IDC

Hovione has announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in partnership with IDC

Global Pharma | 05/12/2023 | By Manvi |  557

Handok, SK Chemicals Ride on Original Ingredients Amid Combo Drug Competition

Pharmaceutical companies are trying to strengthen their competitiveness by combining original drug ingredients amid the competition for combination drugs to treat chronic diseases, such as hypertension and diabetes.

Global Pharma | 04/12/2023 | By Manvi |  866

Biocon Biologics Completes Integration of Viatris' Biosimilar Business in 31 Countries in Europe

Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd announced that the integration of the Viatris' biosimilars business in 31 European countries has been successfully completed.

Global Pharma | 04/12/2023 | By Manvi |  708

Granules India Limited Receives ANDA Approval for Sildenafil for Oral Suspension

It is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Revatio for Oral Suspension, 10mg/ml, of Viatris Specialty LLC.

Global Pharma | 04/12/2023 | By Manvi |  1155

CPHI and PMEC India 2023 Concludes Showcasing Innovation and Sustainability

The event, held from November 28-30, brought together 50,000 visitors and 1,800 exhibitors from 80 countries.

Global Pharma | 02/12/2023 | By Manvi |  2100